Comparison of 10-Years Disease Outcomes of Rheumatoid Arthritis Patients with Continued Low Disease Activity on Methotrexate with or without Initial Combination Therapy with Infliximab or Prednisone and Sulfasalazine

Author(s):
Bergstra, S.A. (0000-0002-7136-5248); Landewe, R.B.M.; Huizinga, T.W.J. (0000-0001-7033-7520); Allaart, C.F.
Published
2016
Publication type
Article / Letter to editor
Date issued
2016-10-31
Language
English
Is part of
Arthritis and Rheumatology
hdl
1887/94628